These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 3064817)
1. Purification and characterization of a CMP-sialic:LcOse4Cer sialyltransferase from human colorectal carcinoma cell membranes. Liepkans V; Jolif A; Larson G Biochemistry; 1988 Nov; 27(23):8683-8. PubMed ID: 3064817 [TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of Lewis fucolipid antigens in human colorectal carcinoma cells. Partial characterization of LcOse4Cer and H-1 fucolipid fucosyl transferase acceptor activities. Liepkans VA; Larson G Eur J Biochem; 1987 Oct; 168(1):209-17. PubMed ID: 3665917 [TBL] [Abstract][Full Text] [Related]
3. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta. Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739 [TBL] [Abstract][Full Text] [Related]
4. Purification of a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver. Weinstein J; de Souza-e-Silva U; Paulson JC J Biol Chem; 1982 Nov; 257(22):13835-44. PubMed ID: 7142179 [TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of sialosyllactotetraosylceramide in human colorectal carcinoma cells. Jolif A; Liepkans V FEBS Lett; 1988 Mar; 230(1-2):147-50. PubMed ID: 3350149 [TBL] [Abstract][Full Text] [Related]
6. Characterization of two glycolipid: alpha 2-3sialyltransferases, SAT-3 (CMP-NeuAc:nLcOse4Cer alpha 2-3sialyltransferase) and SAT-4 (CMP-NeuAc:GgOse4Cer alpha 2-3sialyltransferase), from human colon carcinoma (Colo 205) cell line. Basu SS; Basu M; Li Z; Basu S Biochemistry; 1996 Apr; 35(16):5166-74. PubMed ID: 8611500 [TBL] [Abstract][Full Text] [Related]
7. Biosynthesis in vitro of sialyl(alpha 2-3)neolactotetraosylceramide by a sialyltransferase from embryonic chicken brain. Basu M; Basu S; Stoffyn A; Stoffyn P J Biol Chem; 1982 Nov; 257(21):12765-9. PubMed ID: 7130178 [TBL] [Abstract][Full Text] [Related]
8. Monosialoganglioside biosynthesis by subcellular membranes of rhabdomyosarcoma cell lines differing in metastatic potential. Liepkans VA Int J Cancer; 1990 May; 45(5):961-7. PubMed ID: 2335400 [TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of alpha (2-6)-sialyltransferase from human liver. Sticher U; Gross HJ; Brossmer R Glycoconj J; 1991 Feb; 8(1):45-54. PubMed ID: 1823612 [TBL] [Abstract][Full Text] [Related]
10. Sialyltransferase of the 13762 rat mammary ascites tumor cells. Pratt T; Sherblom AP Cancer Res; 1984 Mar; 44(3):1148-52. PubMed ID: 6692399 [TBL] [Abstract][Full Text] [Related]
11. CMP-NeuNAc:poly-alpha-2,8-sialosyl sialyltransferase and the biosynthesis of polysialosyl units in neural cell adhesion molecules. McCoy RD; Vimr ER; Troy FA J Biol Chem; 1985 Oct; 260(23):12695-9. PubMed ID: 4044605 [TBL] [Abstract][Full Text] [Related]
12. Purification to homogeneity of GD3 synthase and partial purification of GM3 synthase from rat brain. Gu XB; Gu TJ; Yu RK Biochem Biophys Res Commun; 1990 Jan; 166(1):387-93. PubMed ID: 2302211 [TBL] [Abstract][Full Text] [Related]
13. Purification to apparent homogeneity by immunoaffinity chromatography and partial characterization of the GM3 ganglioside-forming enzyme, CMP-sialic acid:lactosylceramide alpha 2,3-sialyltransferase (SAT-1), from rat liver Golgi. Melkerson-Watson LJ; Sweeley CC J Biol Chem; 1991 Mar; 266(7):4448-57. PubMed ID: 1999428 [TBL] [Abstract][Full Text] [Related]
14. Purification and partial characterization of an alpha-2,8-sialyltransferase from human erythroleukemia K562 cells. D'Andrea G; Di Ciccio L; Brisdelli F; D'Alessandro AM; Bozzi A; Oratore A Prep Biochem Biotechnol; 2001 Nov; 31(4):355-68. PubMed ID: 11765900 [TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of CMP-NeuAc:GM1 (Gal beta 1-4GalNAc) alpha 2-3 sialyltransferase from rat brain. Gu TJ; Gu XB; Ariga T; Yu RK FEBS Lett; 1990 Nov; 275(1-2):83-6. PubMed ID: 2262006 [TBL] [Abstract][Full Text] [Related]
16. Increased CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues. Dall'Olio F; Malagolini N; di Stefano G; Minni F; Marrano D; Serafini-Cessi F Int J Cancer; 1989 Sep; 44(3):434-9. PubMed ID: 2476402 [TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of CMP-N-acetylneuraminic acid:lactosylceramide (alpha 2-3) sialyltransferase (GM3-synthase) from rat brain. Preuss U; Gu X; Gu T; Yu RK J Biol Chem; 1993 Dec; 268(35):26273-8. PubMed ID: 8253749 [TBL] [Abstract][Full Text] [Related]
19. Biosynthesis in vitro of disialosylneolactotetraosylceramide by a solubilized sialyltransferase from embryonic chicken brain. Higashi H; Basu M; Basu S J Biol Chem; 1985 Jan; 260(2):824-8. PubMed ID: 3838172 [TBL] [Abstract][Full Text] [Related]
20. Sialyltransferase activity and hepatic tumor growth in a nude mouse model of colorectal cancer metastases. Harvey BE; Toth CA; Wagner HE; Steele GD; Thomas P Cancer Res; 1992 Apr; 52(7):1775-9. PubMed ID: 1312899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]